Global Spinal Muscular Atrophy Treatment Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Disease Type;
Type 1, Type 2, Type 3 and Type 4.Segmented by Treatment;
Gene Therapy and Drug - Spinraza, RG6083 (Olesoxime) and RG7916.Segmented by Route of Administration;
Oral and Intrathecal.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Spinal Muscular Atrophy Treatment Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 95.0 |
2021 | 104.9 |
2022 | 106.4 |
2023 | 118.0 |
2024 | 139.7 |
2025 | 157.5 |
2026 | 171.6 |
2027 | 188.0 |
2028 | 211.0 |
2029 | 223.9 |
2030 | 241.8 |
In the year 2023, the Global Spinal Muscular Atrophy Treatment Market was valued at USD 2,042.94 million. The size of this market is expected to increase to USD 7,479.69 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 20.4%.
Global Spinal Muscular Atrophy Treatment Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Spinal Muscular Atrophy Treatment Market |
Study Period | 2020 - 2030 |
Base Year (for Spinal Muscular Atrophy Treatment Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Spinal Muscular Atrophy Treatment Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Spinal Muscular Atrophy Treatment Market Analysis
In this report, the Global Spinal Muscular Atrophy Treatment Market has been segmented by Disease Type, Treatment, Route of Administration and Geography.
Global Spinal Muscular Atrophy Treatment Market, Segmentation by Disease Type
The Global Spinal Muscular Atrophy Treatment Market has been segmented by Disease Type into Type 1, Type 2, Type 3 and Type 4. The complete Global Spinal Muscular Atrophy Treatment Market segmentation by Disease Type can be seen below:
- Global Spinal Muscular Atrophy Treatment Market, By Disease Type
- Type 1
- Type 2
- Type 3
- Type 4
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Disease Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Disease Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. The high-performance plastics market, by type fluoropolymers, hppa, polyphenylene sulfide, liquid crystal polymers, and polyimides. Entertainment robots market by product type robot toys, educational robots, robotic companion pets. The polymer binder market is segmented by type as vinyl acetate, acrylic, styrene acrylic, and latex. The polyglycerol market is segmented by type as polyglycerol polyricinoleate, polyglycerol esters, polyglycerol sebacate, and others. The paper dyes market is segmented by type as acidic, basic, and direct. The outage management system market is segmented by type as standalone and integrated. Automotive acoustic engineering services market by vehicle type is passenger vehicle, commercial vehicle, and electric vehicle. Data center structured cabling market, by cable type is category 5e, category 6, category 6a, category 7, others.
Global Spinal Muscular Atrophy Treatment Market, by Disease Type (USD Million), 2020 - 2030
# | Type 1 | Type 2 | Type 3 | Type 4 |
---|---|---|---|---|
2020 | 72.4 | 53.8 | 65.6 | 66.3 |
2021 | 79.5 | 63.8 | 76.2 | 67.7 |
2022 | 81.0 | 71.7 | 86.7 | 70.5 |
2023 | 92.1 | 74.6 | 101.1 | 81.9 |
2024 | 95.7 | 85.2 | 101.2 | 92.4 |
2025 | 105.3 | 89.9 | 104.4 | 98.8 |
2026 | 108.5 | 92.9 | 104.6 | 102.6 |
2027 | 123.8 | 102.6 | 112.0 | 121.2 |
2028 | 143.3 | 113.5 | 113.4 | 129.4 |
2029 | 160.5 | 132.7 | 125.3 | 134.0 |
2030 | 184.0 | 139.8 | 142.2 | 141.1 |
Global Spinal Muscular Atrophy Treatment Market, Segmentation by Treatment
The Global Spinal Muscular Atrophy Treatment Market has been segmented by Treatment into Gene Therapy and Drug. The complete Global Spinal Muscular Atrophy Treatment Market segmentation by Treatment can be seen below:
- Global Spinal Muscular Atrophy Treatment Market, By Treatment
- Gene Therapy
- Drug
- Spinraza
- RG6083 (Olesoxime)
- RG7916
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Treatments mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Treatment is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. Based on the treatment type, the spinal muscular atrophy prognosis is gene replacement therapy and drug therapy.
Global Spinal Muscular Atrophy Treatment Market, by Treatment (USD Million), 2020 - 2030
# | Gene Therapy | Drug |
---|---|---|
2020 | 80.3 | 65.4 |
2021 | 89.8 | 73.8 |
2022 | 92.7 | 75.2 |
2023 | 108.2 | 87.4 |
2024 | 109.4 | 95.8 |
2025 | 120.3 | 96.2 |
2026 | 134.2 | 109.9 |
2027 | 140.6 | 114.4 |
2028 | 167.9 | 125.9 |
2029 | 172.9 | 135.6 |
2030 | 181.8 | 138.8 |
Global Spinal Muscular Atrophy Treatment Market, Segmentation by Route of Administration
The Global Spinal Muscular Atrophy Treatment Market has been segmented by Route of Administration into Oral and Intrathecal. The complete Global Spinal Muscular Atrophy Treatment Market segmentation by Route of Administration can be seen below:
- Global Spinal Muscular Atrophy Treatment Market, By Route of Administration
- Oral
- Intrathecal
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Route of Administrations mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Route of Administration is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. By the application service, the paper and paperboard packaging market is segmented into food, beverage, healthcare, personal & homecare. By the administration, the automated passenger counting system market is segmented into railways, roadways, airways. By the administration, the cognitive security market is segmented into cognitive threat analytics, predictive maintenance, cross-investigation analytics. By the administration, the virtual mobile infrastructure market is segmented into bfsi, it and telecommunication, healthcare, government. On the basis of end-use, the identity and access management market (iam) is segmented into bfsi, telecom and it, energy, oil and gas, education, public sector and utilities, healthcare, and manufacturing. By the administration, the containers as a service market is segmented into bfsi, it and telecommunication, healthcare, government. By the administration, the app analytics market is segmented into marketing/advertising analytics, revenue analytics, in-app performance analytics. Pressure transmitter market segmentation by applicationflow, level, pressure. Content intelligence market by applicationis banking, financial services & insurance, government & public sector, healthcare & life sciences, it & telecommunications, manufacturing, media, entertainment, retail, consumer goods, travel, hospitality.
Global Spinal Muscular Atrophy Treatment Market, by Route of Administration (USD Million), 2020 - 2030
# | Oral | Intrathecal |
---|---|---|
2020 | 97.8 | 57.0 |
2021 | 101.8 | 60.9 |
2022 | 105.2 | 72.4 |
2023 | 106.3 | 77.5 |
2024 | 113.9 | 86.6 |
2025 | 128.3 | 99.2 |
2026 | 135.7 | 108.5 |
2027 | 157.3 | 117.9 |
2028 | 179.8 | 119.7 |
2029 | 188.2 | 122.8 |
2030 | 206.4 | 144.0 |
Global Spinal Muscular Atrophy Treatment Market, Segmentation by Geography
In this report, the Global Spinal Muscular Atrophy Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Spinal Muscular Atrophy Treatment Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Spinal Muscular Atrophy Treatment Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Spinal Muscular Atrophy Treatment in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Spinal Muscular Atrophy Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Spinal Muscular Atrophy Treatment Market is driven by; Rising importance of rare diseases, Increasing initiatives for creating awareness of SMA and Growing research initiatives by market players for developing a treatment for SMA.
- While the growth of Global Spinal Muscular Atrophy Treatment Market is currently hindered by; Limited access to treatment of SMA.
- The new opportunities in Global Spinal Muscular Atrophy Treatment Market will be discussed in detail in the full report.
- Rising importance of rare diseases.
- Increasing initiatives for creating awareness of SMA.
- Growing research initiatives by market players for developing a treatment for SMA.
- Limited access to treatment of SMA.
- Global Spinal Muscular Atrophy Treatment Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Spinal Muscular Atrophy Treatment Market. The opportunity map (by market segments; Disease Type, Treatment and Route of Administration) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Spinal Muscular Atrophy Treatment Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Spinal Muscular Atrophy Treatment Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Spinal Muscular Atrophy Treatment Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Spinal Muscular Atrophy Treatment Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Spinal Muscular Atrophy Treatment Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Spinal Muscular Atrophy Treatment Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Spinal Muscular Atrophy Treatment Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Spinal Muscular Atrophy Treatment Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Spinal Muscular Atrophy Treatment Market include, Biogen, Ionis Pharmaceuticals, Inc., F. Hoffmann - La Roche Ltd, Avexis, Inc., Novartis AG and Cytokinetics.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Treatment
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
- Market Opportunity Map
- Global Spinal Muscular Atrophy Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising importance of rare diseases
- Increasing initiatives for creating awareness of SMA
- Growing research initiatives by market players for developing a treatment for SMA
- Restraints
- Limited access to treatment of SMA
- Opportunities
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Spinal Muscular Atrophy Treatment Market, By Disease Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Type 1
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Type 2
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Type 3
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Type 4
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Type 1
- Global Spinal Muscular Atrophy Treatment Market, By Treatment, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Drug
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Spinraza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- RG6083 (Olesoxime)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- RG7916
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Spinraza
- Gene Therapy
- Global Spinal Muscular Atrophy Treatment Market, By Route of Administration, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Intrathecal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Oral
- Global Spinal Muscular Atrophy Treatment Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Spinal Muscular Atrophy Treatment Market, By Disease Type, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Biogen
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Ionis Pharmaceuticals, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. Hoffmann - La Roche Ltd
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Avexis, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novartis AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Cytokinetics, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Biogen
- Analyst Views
- Future Outlook of the Market